Experimental Gene-Editing Drug Infusion Investigated for Long-Term LDL Reduction
NY Times Science ·
·
1 min read ·
Social Sciences
Read research and analysis on Experimental Gene-Editing Drug Infusion Investigated for Long-Term LDL Reduction published by ICANEWS, a global research journal for emerging researchers.
Key Takeaways
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial.
Why This Matters
The observed long-term reduction in LDL following a single infusion of the experimental gene-editing drug might suggest a "curative" approach to heart disease prevention.
Overview
Research explored the potential of an experimental gene-editing drug delivered via a single infusion to achieve long-term reduction of low-density lipoprotein (LDL) cholesterol. This investigation was conducted within the framework of a small clinical trial.
Findings
The small trial suggested that a single infusion of an experimental gene-editing drug appeared to reduce LDL cholesterol levels over a long-term period. An expert cited in the source indicated that these results might point towards a "curative" effect.